Internal Medicine, Rheumatology · Joplin, MO
NPI
1902919178
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1027 S Main St Ste 202
Joplin, MO, 64801
Phone (417) 624-0050
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.7M
450,717 services
Medicare patients, 2024
1,158
Average age 74
Drug cost, 2024
$3.1M
15,713 prescriptions
Company payments, 2025
$1,352
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Joseph was code J3262 (injection, tocilizumab, 1 mg), 172,045 times for 33 patients. In total Michael E Joseph billed 450,717 services in 218 codes, and Medicare paid $5.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 172,045 | 33 | $4.59 | $790K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 61,380 | 67 | $9.00 | $553K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 32,150 | 52 | $33.80 | $1.1M |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 21,680 | 71 | $24.75 | $537K |
| J0897 Injection, denosumab, 1 mg | Office | 19,200 | 214 | $20.42 | $392K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 8,705 | 64 | $0.10 | $903 |
| 85025 Blood Count | Office | 4,696 | 926 | $7.56 | $36K |
| 85651 Clinical Chemistry | Office | 4,466 | 828 | $4.14 | $18K |
| 86140 Clinical Chemistry | Office | 4,418 | 828 | $5.03 | $22K |
| 86235 Immunoassay | Office | 4,358 | 403 | $17.45 | $76K |
| 80053 Clinical Chemistry | Office | 3,919 | 929 | $10.28 | $40K |
| 36415 Venipuncture Blood Collection | Office | 3,626 | 888 | $8.60 | $31K |
| 99214 Office E&M - Established | Office | 3,551 | 856 | $85.63 | $304K |
| 95165 Treatment - Miscellaneous | Office | 2,360 | 52 | $9.19 | $22K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,085 | 223 | $0.72 | $1,500 |
By year: 2022 $4.9M for 354,843 services; 2023 $5.9M for 434,355 services; 2024 $5.7M for 450,717 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 4,696 | 926 | $7.56 | $36K |
| 85651 Clinical Chemistry | 4,466 | 828 | $4.14 | $18K |
| 86140 Clinical Chemistry | 4,418 | 828 | $5.03 | $22K |
| 86235 Immunoassay | 4,358 | 403 | $17.45 | $76K |
| 80053 Clinical Chemistry | 3,919 | 929 | $10.28 | $40K |
| 36415 Venipuncture Blood Collection | 3,626 | 888 | $8.60 | $31K |
| 82306 Clinical Chemistry | 2,081 | 872 | $28.64 | $60K |
| 86769 Immunoassay | 2,072 | 644 | $41.02 | $85K |
| 82784 Immunoassay | 1,859 | 175 | $9.03 | $17K |
| 84443 Clinical Chemistry | 1,749 | 748 | $16.42 | $29K |
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Joseph prescribed most often to Medicare patients was Tramadol Hcl, with 902 prescriptions and refills. In total Michael E Joseph wrote 15,713 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl Generic | 902 | 907 | 189 | $12K |
| Levothyroxine Sodium Generic | 803 | 1,723 | 172 | $5,743 |
| Potassium Chloride Generic | 600 | 1,060 | 212 | $10K |
| Methotrexate Methotrexate Sodium | 521 | 860 | 101 | $10K |
| Hydroxychloroquine Sulfate Generic | 476 | 912 | 105 | $19K |
| Gabapentin Generic | 432 | 631 | 91 | $5,252 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 421 | 425 | 246 | $4,587 |
| Celecoxib Generic | 387 | 571 | 90 | $13K |
| Cefdinir Generic | 383 | 383 | 249 | $7,421 |
| Pantoprazole Sodium Generic | 339 | 631 | 87 | $3,641 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 337 | 337 | 47 | $7,107 |
| Omeprazole Generic | 330 | 657 | 75 | $2,883 |
| Amlodipine Besylate Generic | 329 | 696 | 79 | $1,516 |
| Atorvastatin Calcium Generic | 329 | 748 | 80 | $1,868 |
| Meloxicam Generic | 323 | 558 | 97 | $1,244 |
Brand drugs: 1,651 claims; generic drugs: 14,038 claims; opioid claims: 1,335.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Joseph $1,352 ($1,352 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $431.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 38 | $431 |
| GlaxoSmithKline, LLC. GSK | 20 | $318 |
| Pfizer Inc. PFE | 13 | $206 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $132 |
| Abbvie Inc. ABBV | 3 | $78.43 |
| UCB, Inc. UCB.BR | 2 | $54.77 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $43.79 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $35.01 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.9 |
| Janssen Biotech, Inc. JNJ | 1 | $21.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.